• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home StudyGraphics

#VisualAbstract: Thrombolysis Guided by Perfusion Imaging up to 9 Hours after Onset of Stroke

byStudy Graphics | C.WuandConstance Wu
August 22, 2020
in StudyGraphics
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Patients presenting between 4.5 and 9 hours after stroke onset with viable brain tissue who received thrombolytic therapy had better neurological outcomes compared to those receiving placebo.

2. Symptomatic intracranial hemorrhage occurred in a higher number of patients in the thrombolysis group compared to placebo group.

Evidence Rating Level: 1 (Excellent)      

Study Rundown: Guidelines for thrombolytic therapy after ischemic stroke recommend thrombolytic use within 4.5 hours of stroke onset. Imaging with CT and MRI methods are now able to determine whether brain tissue is viable after stroke, giving rise to the possibility of determining if patients should receive thrombolytic therapy based on tissue viability in addition to time since stroke. The EXTEND trial is a phase 3 randomized controlled trial evaluating functional outcomes of patients receiving alteplase or placebo between 4.5 and 9 hours from stroke onset. At 90 days since treatment, patients who received alteplase had better neurological outcomes compared to those treated with placebo. A higher number of patients receiving alteplase experienced symptomatic intracranial hemorrhage than in the placebo group.

This study provides strong evidence for considering information about tissue viability from imaging in deciding whether to administer thrombolytic therapy for patients with delayed hospital presentation after stroke. The study’s strengths are its randomized controlled design and use of either CT or MRI for tissue viability determination. The study was limited by the smaller than planned number of patients recruited for the trial.

Click to read the study in NEJM

RELATED REPORTS

Virtual reality rehabilitation is safe and feasible for upper extremity recovery after subacute ischemic stroke

2 Minute Medicine Rewind February 23, 2026

Tenecteplase not associated with visual improvement in central retinal artery occlusion

©2019 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc

Tags: altepaseischemic strokereperfusionstrokethrombolysis
Previous Post

Quick Take: Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART)

Next Post

Quick Take: Treatment and Long-Term Clinical Outcomes of Incidental Pulmonary Embolism in Patients With Cancer

RelatedReports

Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adults
Chronic Disease

Virtual reality rehabilitation is safe and feasible for upper extremity recovery after subacute ischemic stroke

February 25, 2026
Many new pediatric asthma cases attributable to obesity
Weekly Rewinds

2 Minute Medicine Rewind February 23, 2026

February 23, 2026
siRNA against antithrombin alleviates symptoms of hemophilia [PreClinical]
Neurology

Tenecteplase not associated with visual improvement in central retinal artery occlusion

January 28, 2026
Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adults
Neurology

Functional recovery after maternal ischemic stroke may be commonly favourable

January 26, 2026
Next Post
High rates of over-diagnosis of pulmonary embolism by CT angiography

Quick Take: Treatment and Long-Term Clinical Outcomes of Incidental Pulmonary Embolism in Patients With Cancer

The EXTEND trial: neurological deficits decreased with thrombolysis up to 9 hours after stroke onset

Unrecognized myocardial infarctions associated with embolic cerebral infarctions of undetermined source

Adolescents with mental health problems at higher risk for e-cigarette use

Adolescents with mental health problems at higher risk for e-cigarette use

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Placental abruption during pregnancy is not associated with increased risk of cardiovascular mortality in children
  • Pfizer’s Talzenna combo significantly delays prostate cancer progression
  • Bottom-vented bottles may not reduce gastrointestinal discomfort in infants
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

The Classics in Medicine Paperback Released!

Over the past 30 years, the transition from print to digital media has contributed to an exponential increase in medical literature. In response, 2 Minute Medicine presents 160+ authoritative, physician-written summaries of the most cited landmark trials in medicine.

amazon-logo_blackGet-it-on-iBooks-badge

Click anywhere to close this announcement

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.